Ai-ling L. Tian
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
A protocol for measuring phenotypical facial disease markers in a mouse model of iatrogenic Cushing's syndrome.
Journal: Methods in cell biology
Published: September 10, 2025
Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.
Journal: Cancer cell
Published: September 01, 2025
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.
Journal: Nature medicine
Published: August 12, 2025
Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation.
Journal: Cell reports. Medicine
Published: March 21, 2025
A screening system to determine the effect of bacterial metabolites on MAdCAM-1 expression by transformed endothelial sinusoidal cells.
Journal: Methods in cell biology
Published: March 09, 2025
Autophagy-dependent hepatocyte secretion of DBI/ACBP induced by glucocorticoids determines the pathogenesis of Cushing syndrome.
Journal: Autophagy
Published: December 12, 2024
Pathogenic role of acyl coenzyme A binding protein (ACBP) in Cushing's syndrome.
Journal: Nature metabolism
Published: November 30, 2023
Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillance.
Journal: Oncoimmunology
Published: July 05, 2023
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses.
Journal: Journal for immunotherapy of cancer
Published: June 21, 2023
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Journal: Science (New York, N.Y.)
Published: June 08, 2023
Last Updated: 09/26/2026